GR3027620T3 - Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products - Google Patents

Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products

Info

Publication number
GR3027620T3
GR3027620T3 GR980401798T GR980401798T GR3027620T3 GR 3027620 T3 GR3027620 T3 GR 3027620T3 GR 980401798 T GR980401798 T GR 980401798T GR 980401798 T GR980401798 T GR 980401798T GR 3027620 T3 GR3027620 T3 GR 3027620T3
Authority
GR
Greece
Prior art keywords
bactericidal
permeability
administration
treatment
protein products
Prior art date
Application number
GR980401798T
Other languages
English (en)
Inventor
Lewis H Lambert Jr
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of GR3027620T3 publication Critical patent/GR3027620T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR980401798T 1993-03-12 1998-08-07 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products GR3027620T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3114593A 1993-03-12 1993-03-12
PCT/US1994/002463 WO1994020129A1 (en) 1993-03-12 1994-03-11 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products

Publications (1)

Publication Number Publication Date
GR3027620T3 true GR3027620T3 (en) 1998-11-30

Family

ID=21857874

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980401798T GR3027620T3 (en) 1993-03-12 1998-08-07 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products

Country Status (10)

Country Link
EP (1) EP0690721B1 (el)
AT (1) ATE165976T1 (el)
AU (1) AU6361894A (el)
CA (1) CA2157925C (el)
DE (1) DE69410254T2 (el)
DK (1) DK0690721T3 (el)
ES (1) ES2119185T3 (el)
GR (1) GR3027620T3 (el)
HK (1) HK1010983A1 (el)
WO (1) WO1994020129A1 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
AU7175694A (en) 1993-06-17 1995-01-17 Xoma Corporation Lipopolysaccharide binding protein derivatives
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US5770561A (en) * 1993-07-14 1998-06-23 Xoma Corporation Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
PT759774E (pt) * 1993-09-22 2002-11-29 Xoma Technology Ltd Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
US6759203B1 (en) 1993-09-22 2004-07-06 Xoma Corporation Method for quantifying BPI in body fluids
CN1133634A (zh) * 1993-09-22 1996-10-16 爱克斯欧玛公司 定量体液中的bpi的方法
ES2179095T3 (es) * 1994-01-14 2003-01-16 Xoma Technology Ltd Metodos y materiales anti bacterias gram positivas.
CN1112933C (zh) * 1994-01-14 2003-07-02 爱克索马技术有限公司 抗真菌的方法和物质
US5447913A (en) * 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US6271203B1 (en) 1994-07-07 2001-08-07 Xoma Corporation Anti-protozoan methods and materials
US5646114A (en) * 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries
EP0839156A1 (en) * 1995-07-20 1998-05-06 Xoma Corporation Anti-fungal peptides
ATE198050T1 (de) 1996-05-10 2000-12-15 Xoma Technology Ltd Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
JP2000511190A (ja) * 1996-05-23 2000-08-29 ゾーマ コーポレイション 外傷に起因する出血に見舞われたヒトにおけるｂｐｉタンパク質産物の治療用途
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
NZ335401A (en) * 1996-11-01 2000-12-22 Xoma Corp Therapeutic uses of BPI protein products in cystic fibrosis patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
EP1741440A1 (en) 2005-07-08 2007-01-10 Mellitus S.L. Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
EP0563222B1 (en) * 1990-12-03 1998-02-25 New York University Biologically active bactericidal/permeability-increasing protein fragments

Also Published As

Publication number Publication date
ES2119185T3 (es) 1998-10-01
DE69410254D1 (de) 1998-06-18
ATE165976T1 (de) 1998-05-15
AU6361894A (en) 1994-09-26
CA2157925A1 (en) 1994-09-15
HK1010983A1 (en) 1999-07-02
WO1994020129A1 (en) 1994-09-15
EP0690721A1 (en) 1996-01-10
CA2157925C (en) 2000-06-06
DK0690721T3 (da) 1999-03-08
EP0690721B1 (en) 1998-05-13
DE69410254T2 (de) 1998-12-17

Similar Documents

Publication Publication Date Title
GR3027620T3 (en) Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
CA2157927A1 (en) Therapeutic uses of bactericidal/permeability increasing protein produc ts
CA2119562A1 (en) Method and compositions for the treatment of cerebral palsy
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
AU1679795A (en) Anti-fungal methods and materials
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
AU6586896A (en) Fatty acid treatment
BG101118A (en) Therapeutical compounds
AU3909497A (en) Anti-chlamydial methods and materials
AU2967595A (en) Anti-protozoan methods and materials
RO117833B1 (ro) Metodă pentru tratamentul unei afecţiuni mentale
FR2360314A2 (fr) Nouveaux vaccins perfectionnes a base de fractions ribosomales
AU7970894A (en) Method of treating depressed reticuloendothelial system function
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
CA2235626A1 (en) Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury
MX9304925A (es) Composiciones terapeuticas contra el cancer para profilaxis o para el tratamiento de cancer.
FI961505A0 (fi) Uudet veren koaguloitumisjärjestelmässä terapeuttisesti aktiiviset peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
UA29106A (uk) Спосіб лікування вібраційної хвороби